HomeTechnical SetupAPLLTD
70tech score
/ 100

Alembic Pharmaceuticals Limited (APLLTD) — Technical Setup

₹845.75 +2.39%   Uptrend Volatility Contraction Bullish

As of 2026-09-18 close Sector: Pharma Pharmaceuticals - Indian - Bulk Drugs & Formln

Summary

Alembic Pharmaceuticals Limited is in a uptrend on the daily chart, with the weekly trend bullish and the monthly trend neutral. RSI(14) is 60.7, MACD is above its signal line, ADX reads 19 (weak trend). The stock trades 8.0% above its 200-day average and 15.3% below its 52-week high. Volume in the latest session was 4.6× its 20-day average. Over three months it has outperformed the Nifty 50 by 11.5 percentage points. Nearest support is ₹796.48 and resistance ₹850.70. Its technical score is 70/100 (bullish).

Trend (daily)
Bullish
Trend (weekly)
Bullish
Trend (monthly)
Neutral
RSI (14)
60.72
MACD
Bullish
ADX (14)
18.89
Volume vs 20d avg
4.63×
Support
₹796.48 (−5.8%)
Resistance
₹850.70 (+0.6%)
RS vs Nifty (3M)
+11.46%
RS rating
62.00
Chart pattern
Rectangle / Trading Range · daily

🧮 How the 70/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend18/20
  • Close above 20-day EMA (2.94)3/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA3/3
  • Close above 200-day SMA (8.00)3/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (18.89)1/3
  • Weekly trend up (above a rising 30-week average)2/2
Momentum20/20
  • RSI(14) in the bullish zone (55-70 best) (60.72)6/6
  • MACD line above its signal line4/4
  • MACD line above zero (2.61)3/3
  • 12-day rate of change positive (0.23)3/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months (11.46)2/2
Volume15/20
  • On-balance volume rising over 20 sessions5/5
  • Chaikin Money Flow (20) positive (-0.13)0/5
  • More volume on up days than down days (20 sessions) (1.78)5/5
  • Close above 20-day VWAP (2.38)5/5
Volatility14/20
  • Daily range (ATR%) contained — ≤2.5% scores full (3.02)4/6
  • Price in the upper half of its Bollinger Bands (1.03)3/5
  • Shallow drawdown from the 52-week high (-15.26)3/5
  • Volatility contracting (20-day volatility below its 6-month median) (36.00)4/4
Support / Resistance3/20
  • Room to the next resistance (≥8% scores full) (0.59)0/5
  • Support close below (a tight, definable stop) (5.83)3/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-15.26)0/5

🧭 Regime: Uptrend

Volatility Contraction — Bollinger width is in the 14th percentile of the last six months.

Suits: Trend-following, selectively. The trend is up but not forceful — favour entries near support and keep stops below the 50-day EMA.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the 20/50 EMA Crossover rules for APLLTD — 20-day ema crosses above the 50-day ema.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly◆ Neutral49.553.29
Weekly▲ Bullish59.985.95
Daily▲ Bullish60.722.27

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 19.16.

📶 Volume & VWAP

Relative volume
4.63×
5d / 20d volume
2.57×
Volume ROC (10d)
+94.71%
Up/down volume
1.78×
OBV (20d)
Rising
Chaikin MF (20)
-0.13
VWAP 20d
₹826.12 (+2.38%)
VWAP 50d
₹825.57 (+2.44%)
Anchored VWAP · 52W low
₹781.15 (+8.27%)
Anchored VWAP · 52W high
₹818.20 (+3.37%)
Anchored VWAP · YTD
₹778.47 (+8.64%)
Avg turnover (20d)
₹11 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Today was a 50-day volume climax.

💪 Relative strength

vs Nifty 1M
+6.50%
vs Nifty 3M
+11.46%
vs Nifty 6M
+27.54%
vs Nifty 1Y
-3.49%
RS rating
62.00
Mansfield RS
10.45
vs Pharma index 3M
+0.46%
vs sector peers 3M
-1.22%

APLLTD ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹998.00+18.0%1
Resistance₹955.10+12.9%2
Resistance₹885.70+4.7%3
Resistance₹850.70+0.6%6
Close₹845.75
Support₹796.48−5.8%8
Support₹750.00−11.3%3
Support₹708.80−16.2%4
Support₹640.15−24.3%2

52-week range: ₹635.80 – ₹998.00 (-15.26% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹635.80 (2026-03-23) to ₹860.00 (2026-09-18). Price has retraced 6.4% of it.

RatioPriceDistance
23.6% retracement₹807.09-4.6% nearest
38.2% retracement₹774.36-8.4%
50.0% retracement₹747.90-11.6%S/R confluence
61.8% retracement₹721.44-14.7%
78.6% retracement₹683.78-19.1%
127.2% extension₹920.98+8.9%
161.8% extension₹998.56+18.1%
200.0% extension₹1,084.20+28.2%

🕯️ Candlesticks (last 5 sessions)

No classic candlestick pattern in the last five sessions.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

📐 Chart pattern

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
AUROPHARMAAurobindo Pharma Limited ₹1,734 +2.60% 94 Uptrend 84.00
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited ₹102.13 +0.40% 85 Strong Uptrend 86.00
ACUTAASAcutaas Chemicals Limited ₹3,440 +3.78% 85 Uptrend 93.00
KOPRANKopran Limited ₹277.60 +3.35% 85 Strong Uptrend 96.00
BAFNAPHBafna Pharmaceuticals Limited ₹317.20 +1.99% 84 Strong Uptrend 98.00
KILITCHKilitch Drugs (India) Limited ₹191.45 +1.47% 84 Uptrend 63.00
CAPLIPOINTCaplin Point Laboratories Limited ₹2,749 +5.85% 83 Uptrend 83.00
GLANDGland Pharma Limited ₹2,962 +1.86% 83 Strong Uptrend 91.00
JUBLPHARMAJubilant Pharmova Limited ₹1,065 +5.27% 80 Strong Uptrend 64.00
STARStrides Pharma Science Limited ₹1,220 +1.63% 80 Strong Uptrend 81.00
🔗 More on APLLTD

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ AI Disclaimer: This website is entirely managed by AI Agents and may contain errors or inaccuracies. Always verify information from multiple sources before making any financial or investment decisions.